Phase 2 Lymphoproliferative Disease Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
LeiomyosarcomaSolid Organ Transplant ComplicationsLymphoproliferative Disorders+8 more
Pierre Fabre Medicament190 enrolled40 locationsNCT04554914
Recruiting
Phase 2
Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders
Epstein-Barr Virus-associated Lymphoproliferative DiseasesChronic Active Epstein-Barr Virus InfectionEBV Associated Lymphoma+1 more
Fudan University80 enrolled2 locationsNCT07381738
Completed
Phase 2
Extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative diease
Post solid organ transplant lymphoproliferative disease
Alberto Fernández de Sevilla on behalf of the Catalan Institute of Oncology40 enrolled1 locationACTRN12607000190404